Key result
Mean platelet volume shows a U-shaped link to HF mortality, raising risk ~27% per unit increase.
Why the study?
Mean platelet volume has been proposed as a predictor of 6-month mortality in Chinese patients with heart failure, but evidence supporting this association remains limited.
Does baseline mean platelet volume predict 6-month all-cause mortality in Chinese patients with heart failure?
Cohort (n=1,905)
No
Does baseline mean platelet volume predict 6-month all-cause mortality in Chinese patients with heart failure?
Effect estimate: RR 1.27 (95% CI 1.01-1.61)
p-value: p=0.0434
Baseline mean platelet volume exhibits a U-shaped association with 6-month all-cause mortality in non-obese Chinese patients with heart failure, suggesting its potential utility as a prognostic marker.
MPV may aid mortality prediction in Chinese HF; leaves open incremental value beyond standard scores in prospective studies.
Background Mean Platelet Volume (MPV) has been proposed as a potential predictor of increased mortality risk at 6 months among Chinese patients with heart failure (HF). However, the current evidence supporting this association is limited. Methods This study aimed to investigate the relationship between MPV and HF short-term survival status. The data was obtained from a publicly accessible HF database in Zigong, Sichuan, and included information on 2008 Chinese patients. Baseline MPV was considered as the exposure while HF short-term survival status was the outcome. Two models, a binary logistic regression model and a two-piecewise linear model, were used to analyze the data. Results The study revealed a U-shaped relationship between MPV and all-cause mortality in HF patients. When MPV levels were less than 9.8, every unit increase in MPV was associated with a 91% reduction (RR: 0.09; 95% CI: 0.03-0.24; P=0.0001) in the risk of death over the next six months. In contrast, at MPV levels above 9.8, each unit increase in MPV was linked to a 27% increase (RR: 1.27; 95% CI: 1.01-1.61; P=0.0434) in the probability of dying within the same period. Stratification by obesity status revealed no significant association between MPV and death in the obese population, while the same U-shaped association was observed among non-obese participants. Conclusion The present study provides evidence of a U-shaped association between MPV and short-term survival in Chinese patients with heart failure. These findings suggest that MPV may serve as a potential prognostic marker for HF. However, further studies are needed to validate these results and to explore the underlying mechanisms of this association. The observed U-shaped association did not apply to obese patients, suggesting that the effect of MPV on mortality risk in HF patients may be influenced by body weight.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) conducted a cohort in Heart failure (n=1,905). Mean Platelet Volume (MPV) was evaluated on 6-month all-cause mortality (RR 1.27, 95% CI 1.01-1.61, p=0.0434). Mean platelet volume demonstrated a U-shaped association with 6-month all-cause mortality in Chinese patients with heart failure, with each unit increase above 9.8 fL increasing mortality risk by 27%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: